These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8099888)

  • 1. Vagal stimulation of rat exocrine pancreatic secretion occurs via multiple mediators.
    Nelson MT; Debas HT; Mulvihill SJ
    Gastroenterology; 1993 Jul; 105(1):221-8. PubMed ID: 8099888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat exocrine pancreatic secretion by vagal stimulation occurs via multiple mediators.
    He X; Nelson MT; Debas HT
    Chin Med Sci J; 1996 Jun; 11(2):73-7. PubMed ID: 9387412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapancreatic cholecystokinin mediates vagally stimulated exocrine secretion from the rat pancreas.
    He X; Nelson MT; Debas HT
    Chin Med Sci J; 1996 Mar; 11(1):32-5. PubMed ID: 9206116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagal regulation of GRP, gastric somatostatin, and gastrin secretion in vitro.
    Nishi S; Seino Y; Takemura J; Ishida H; Seno M; Chiba T; Yanaihara C; Yanaihara N; Imura H
    Am J Physiol; 1985 Apr; 248(4 Pt 1):E425-31. PubMed ID: 2858978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-type natriuretic peptide stimulates pancreatic exocrine secretion in the rat: role of vagal afferent and efferent pathways.
    Sabbatini ME; Rodríguez MR; Dabas P; Vatta MS; Bianciotti LG
    Eur J Pharmacol; 2007 Dec; 577(1-3):192-202. PubMed ID: 17900562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by CCK of ascending contraction elicited by mucosal stimulation in the duodenum of the rat.
    Giralt M; Vergara P
    Neurogastroenterol Motil; 2000 Apr; 12(2):173-80. PubMed ID: 10877605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagal regulation of insulin, glucagon, and somatostatin secretion in vitro in the rat.
    Nishi S; Seino Y; Ishida H; Seno M; Taminato T; Sakurai H; Imura H
    J Clin Invest; 1987 Apr; 79(4):1191-6. PubMed ID: 2881948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats.
    Li Y; Owyang C
    Gastroenterology; 1994 Aug; 107(2):525-31. PubMed ID: 8039628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs.
    Ahrén B; Paquette TL; Taborsky GJ
    Am J Physiol; 1986 Feb; 250(2 Pt 1):E212-7. PubMed ID: 2869692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide, and somatostatin.
    Guzman S; Chayvialle JA; Banks WA; Rayford PL; Thompson JC
    Surgery; 1979 Aug; 86(2):329-36. PubMed ID: 462378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats.
    Lloyd KC; Raybould HE; Walsh JH
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G287-92. PubMed ID: 1357976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK-8 activates hepatic vagal C-fiber afferents.
    Cox JE; Randich A
    Brain Res; 1997 Nov; 776(1-2):189-94. PubMed ID: 9439812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin-sensitive vagal stimulation-induced gastric acid secretion in the rat: evidence for cholinergic vagal afferents.
    Sharkey KA; Oland LD; Kirk DR; Davison JS
    Br J Pharmacol; 1991 Aug; 103(4):1997-2003. PubMed ID: 1680518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
    Sabbatini ME; Rodríguez MR; Corbo NS; Vatta MS; Bianciotti LG
    Eur J Pharmacol; 2005 Nov; 524(1-3):67-74. PubMed ID: 16263110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an antral mucosectomy, L-364,718 and atropine on cephalic phase of gastric and pancreatic secretion in dogs.
    Konturek SJ; Bielański W; Solomon TE
    Gastroenterology; 1990 Jan; 98(1):47-55. PubMed ID: 2403431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of naloxone on basal and vagus nerve-induced secretions of GRP, gastrin, and somatostatin from the isolated perfused rat stomach.
    Nishi S; Seino Y; Kitano N; Seno M; Tsuji K; Kurose T; Taminato T; Tsuda K; Yanaihara C; Yanaihara N
    Life Sci; 1987 Oct; 41(15):1787-93. PubMed ID: 2889122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat.
    Takahashi T; Owyang C
    J Physiol; 1995 Apr; 484 ( Pt 2)(Pt 2):481-92. PubMed ID: 7602539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs.
    Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.